Cargando…
Results of the treatment of patients with exudative AMD during the COVID-19 pandemic()
BACKGROUND AND OBJECTIVE: The SARS-CoV-2 pandemic has caused chaos in all health systems on the planet. It has been difficult to cope with COVID 19, but also to maintain the activity in other specialties. In ophthalmology, the scientific societies recommended providing urgent care, including the int...
Autores principales: | Arruabarrena, C., Montejano-Milner, R., de Aragón, F., Allendes, G., Teus, M.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863427/ https://www.ncbi.nlm.nih.gov/pubmed/35523464 http://dx.doi.org/10.1016/j.oftale.2021.02.012 |
Ejemplares similares
-
Resultados del tratamiento de los pacientes con DMAE exudativa durante la pandemia por COVID-19
por: Arruabarrena, C., et al.
Publicado: (2022) -
Impact on Visual Acuity in Neovascular Age Related Macular Degeneration (nAMD) in Europe Due to COVID-19 Pandemic Lockdown
por: Arruabarrena, Carolina, et al.
Publicado: (2021) -
Short-term outcomes of patients with neovascular exudative AMD: the effect of COVID-19 pandemic
por: Borrelli, Enrico, et al.
Publicado: (2020) -
Intravitreal Combination of Dexamethasone Sodium Phosphate and Bevacizumab in The Treatment of Exudative AMD
por: Vakalis, N., et al.
Publicado: (2015) -
Real-World Results of Aflibercept versus Ranibizumab for the Treatment of Exudative AMD Using a Fixed Regimen
por: Providência, Joana, et al.
Publicado: (2018)